203 related articles for article (PubMed ID: 35942129)
1. Newborn screening for spinal muscular atrophy in Japan: One year of experience.
Sawada T; Kido J; Sugawara K; Yoshida S; Ozasa S; Nomura K; Okada K; Fujiyama N; Nakamura K
Mol Genet Metab Rep; 2022 Sep; 32():100908. PubMed ID: 35942129
[TBL] [Abstract][Full Text] [Related]
2. Spinal Muscular Atrophy Type I With False Negative in Newborn Screening: A Case Report.
Hashimoto K; Yokokawa M; Yamashita D; Yuge K; Otsubo Y
Cureus; 2023 Jul; 15(7):e42382. PubMed ID: 37621829
[TBL] [Abstract][Full Text] [Related]
3. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
[TBL] [Abstract][Full Text] [Related]
4. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
[TBL] [Abstract][Full Text] [Related]
5. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
[TBL] [Abstract][Full Text] [Related]
6. Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR.
Takeuchi A; Tode C; Nishino M; Wijaya YOS; Niba ETE; Awano H; Takeshima Y; Saito T; Saito K; Lai PS; Bouike Y; Nishio H; Shinohara M
Kobe J Med Sci; 2019 Nov; 65(3):E95-E99. PubMed ID: 32029694
[TBL] [Abstract][Full Text] [Related]
7. Pilot Study on Newborn Screening for Spinal Muscular Atrophy.
Fonseca H; Ribeiro D; Guimarães F; Pinto C; Marcão A; Sousa C; Carvalho I; Lopes L; Rodrigues D; Rocha H; Vilarinho L
Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711122
[TBL] [Abstract][Full Text] [Related]
8. Alberta Spinal Muscular Atrophy Newborn Screening-Results from Year 1 Pilot Project.
Niri F; Nicholls J; Baptista Wyatt K; Walker C; Price T; Kelln R; Hume S; Parboosingh J; Lilley M; Kolski H; Ridsdale R; Muranyi A; Mah JK; Bulman DE
Int J Neonatal Screen; 2023 Jul; 9(3):. PubMed ID: 37606479
[TBL] [Abstract][Full Text] [Related]
9. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
[TBL] [Abstract][Full Text] [Related]
10. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
[TBL] [Abstract][Full Text] [Related]
12. Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan.
Kimizu T; Ida S; Okamoto K; Awano H; Niba ETE; Wijaya YOS; Okazaki S; Shimomura H; Lee T; Tominaga K; Nabatame S; Saito T; Hamazaki T; Sakai N; Saito K; Shintaku H; Nozu K; Takeshima Y; Iijima K; Nishio H; Shinohara M
Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34287247
[TBL] [Abstract][Full Text] [Related]
13. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
[TBL] [Abstract][Full Text] [Related]
14. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
[TBL] [Abstract][Full Text] [Related]
15. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
[TBL] [Abstract][Full Text] [Related]
17. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA.
Ar Rochmah M; Harahap NIF; Niba ETE; Nakanishi K; Awano H; Morioka I; Iijima K; Saito T; Saito K; Lai PS; Takeshima Y; Takeuchi A; Bouike Y; Okamoto M; Nishio H; Shinohara M
Brain Dev; 2017 Oct; 39(9):774-782. PubMed ID: 28522225
[TBL] [Abstract][Full Text] [Related]
18. Spinal Muscular Atrophy: New Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
Kobe J Med Sci; 2019 Jul; 65(2):E44-E48. PubMed ID: 31956255
[TBL] [Abstract][Full Text] [Related]
19. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
[No Abstract] [Full Text] [Related]
20. Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis.
Wijaya YOS; Nishio H; Niba ETE; Shiroshita T; Kato M; Bouike Y; Tode C; Ar Rochmah M; Harahap NIF; Nurputra DK; Okamoto K; Saito T; Takeuchi A; Lai PS; Yamaguchi S; Shinohara M
Genet Test Mol Biomarkers; 2021 Apr; 25(4):293-301. PubMed ID: 33877896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
